non glp 1 weight loss drugs π¨ GLP-1 DRUGS: A BREAKTHROUGH OR A NEW RISK? π€π, π₯ βThe Hidden Side of GLP-1s: Could Weight Loss Trigger Eating Disorders?β π₯, GLP-1 medications such as semaglutide and tirzepatide Rx Trends: Real-World Data on
Description
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome

For the successful clinical implementation of these newly developed multiple hormone receptor agonists, it is essential to elucidate their fundamental mechanisms of action, and at the same time to confirm their efficacy and safety in real-world applications

The most pronounced effects were observed in glial cells, the metabolic and inflammatory support system of the brain, suggesting that improving the brains environment may be as important as targeting neurons directly

Similarly, the utility of diagnosis codes to identify falls and other risk factors for fracture is limited, and therefore differential fall patterns between the two groups may still be a cause of residual confounding

Lancet Diabetes Endocrinol 2016

(2024) 17:sfae018
